The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
The role of lipid peroxidation in neurological disorders
Open accessAbstract
There has been much evidence demonstrating the involvement of oxidative stress in the pathology of neurological disorders. Moreover, the vulnerability of the central nervous system to reactive oxygen species mediated injury is well established since neurons consume large amounts of oxygen, the brain has many areas containing high iron content, and neuronal mitochondria generate large amounts of hydrogen peroxide. Furthermore, neuronal membranes are rich in polyunsaturated fatty acids, which are particularly susceptible to oxidative stress. Recently, the biological roles of products produced by lipid peroxidation have received much attention, not only for their pathological mechanisms associated with neurological disorders, but also for their practical clinical applications as biomarkers. Here, we discuss the production mechanisms of reactive oxygen species in some neurological disorders, including Alzheimer's disease, Down syndrome, Parkinson's disease, and stroke. We also describe lipid peroxidation biomarkers for evaluating oxidative stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aging: a theory based on free radical and radiation chemistry
Harman, D. (1956) · Journal of Gerontology · doi:10.1093/geronj/11.3.298 · Cited by 8,567
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Oxidative stress: oxidants and antioxidants
Sies, H. (1997) · Experimental Physiology · doi:10.1113/expphysiol.1997.sp004024 · Cited by 4,566
Oxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380
Free Radical Lipid Peroxidation: Mechanisms and Analysis
Yin, H., Xu, L., & Porter, N. A. (2011) · Chemical Reviews · doi:10.1021/cr200084z · Cited by 1,937
Morrow, J. D., Hill, K. E., Burk, R. F., Nammour, T. M., Badr, K. F., & Roberts, L. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9383 · Cited by 1,899
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844
Iron, brain ageing and neurodegenerative disorders
Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801
4-Hydroxy-2-nonenal: a product and mediator of oxidative stress
Uchida, K. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00014-6 · Cited by 1,164
Sian, J., Dexter, D. T., Lees, A. J., Daniel, S., Agid, Y., Javoy‐Agid, F., Jenner, P., & Marsden, C. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360305 · Cited by 1,161
Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide
Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02173-6 · Cited by 1,114
Huang, X., Atwood, C. S., Hartshorn, M. A., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Cuajungco, M. P., Gray, D. N., Lim, J., Moir, R. D., et al. (1999) · Biochemistry · doi:10.1021/bi990438f · Cited by 1,107
Sayre, L. M., Zelasko, D. A., Harris, P. L. R., Perry, G., Salomon, R. G., & Smith, M. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052092.x · Cited by 1,007
Lipid peroxidation: Mechanisms, inhibition, and biological effects
Niki, E., Yoshida, Y., Saito, Y., & Noguchi, N. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.072 · Cited by 875
Praticò, D., Uryu, K., Leight, S., Trojanoswki, J. Q., & Lee, V. M.-Y. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04183.2001 · Cited by 777
Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro
Busciglio, J., & Yankner, B. A. (1995) · Nature · doi:10.1038/378776a0 · Cited by 741
cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain
Lund, E. G., Guileyardo, J. M., & Russell, D. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7238 · Cited by 668
Mammalian lipoxygenases: molecular structures and functions
Yamamoto, S. (1992) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(92)90297-9 · Cited by 571
Free radical biology and medicine: it's a gas, man!
Pryor, W. A., Houk, K. N., Foote, C. S., Fukuto, J. M., Ignarro, L. J., Squadrito, G. L., & Davies, K. J. A. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00614.2005 · Cited by 465
Formation of Isoprostane-like Compounds (Neuroprostanes) in Vivo from Docosahexaenoic Acid
Roberts, L. J., Montine, T. J., Markesbery, W. R., Tapper, A. R., Hardy, P., Chemtob, S., Dettbarn, W. D., & Morrow, J. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13605 · Cited by 418
Stroke epidemiology in the developing world
Feigin, V. L. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66755-4 · Cited by 413
Brain Peroxidase and Catalase in Parkinson Disease
Ambani, L. M., Van Woert, M. H., & Murphy, S. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490440064010 · Cited by 402
Lütjohann, D., Papassotiropoulos, A., Björkhem, I., Locatelli, S., Bagli, M., Oehring, R. D., Schlegel, U., Jessen, F., Rao, M. L., von Bergmann, K., et al. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32052-6 · Cited by 382
Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain
BJÖRKHEM, I. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01725.x · Cited by 381
Lipid peroxidation and neurodegenerative disease
Reed, T. T. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.06.027 · Cited by 379
Reactive oxygen species and the modulation of stroke
Crack, P. J., & Taylor, J. M. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.01.019 · Cited by 378
Kinumi, T., Kimata, J., Taira, T., Ariga, H., & Niki, E. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.110 · Cited by 367
Control of Oxygenation in Lipoxygenase and Cyclooxygenase Catalysis
Schneider, C., Pratt, D. A., Porter, N. A., & Brash, A. R. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.04.007 · Cited by 322
Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis
Etminan, M., Gill, S. S., & Samii, A. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70097-1 · Cited by 279
Reperfusion-Induced Oxidative/Nitrative Injury to Neurovascular Unit After Focal Cerebral Ischemia
Gürsoy-Özdemir, Y., Can, A., & Dalkara, T. (2004) · Stroke · doi:10.1161/01.str.0000126044.83777.f4 · Cited by 275
Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment
Markesbery, W. R., Kryscio, R. J., Lovell, M. A., & Morrow, J. D. (2005) · Annals of Neurology · doi:10.1002/ana.20629 · Cited by 273
Oxidative damage in Parkinson disease: Measurement using accurate biomarkers
Seet, R. C. S., Lee, C.-Y. J., Lim, E. C. H., Tan, J. J. H., Quek, A. M. L., Chong, W.-L., Looi, W.-F., Huang, S.-H., Wang, H., Chan, Y.-H., et al. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.11.026 · Cited by 257
Increased CSF F 2 -isoprostane concentration in probable AD
Montine, T. J., Beal, M. F., Cudkowicz, M. E., O’Donnell, H., Margolin, R. A., McFarland, L., Bachrach, A. F., Zackert, W. E., Roberts, L. J., & Morrow, J. D. (1999) · Neurology · doi:10.1212/wnl.52.3.562 · Cited by 251
Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk
Zhang, S. M., Hernán, M. A., Chen, H., Spiegelman, D., Willett, W. C., & Ascherio, A. (2002) · Neurology · doi:10.1212/01.wnl.0000028688.75881.12 · Cited by 240
Ghilarducci, D. P., & Tjeerdema, R. S. (1995) · Reviews of Environmental Contamination and Toxicology · doi:10.1007/978-1-4612-2550-8_2 · Cited by 230
Lloret, A., Badía, M.-C., Mora, N. J., Pallardó, F. V., Alonso, M.-D., & Viña, J. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1033 · Cited by 222
The monoclonal antibody specific for the 4‐hydroxy‐2‐nonenal histidine adduct
Toyokuni, S., Miyake, N., Hiai, H., Hagiwara, M., Kawakishi, S., Osawa, T., & Uchida, K. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00033-6 · Cited by 213
Using Isoprostanes as Biomarkers of Oxidative Stress: Some Rarely Considered Issues
Halliwell, B., & Lee, C. Y. J. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2934 · Cited by 191
Effect of 4-Hydroxy-2-nonenal Modification on α-Synuclein Aggregation
Qin, Z., Hu, D., Han, S., Reaney, S. H., Di Monte, D. A., & Fink, A. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608126200 · Cited by 191
Reed, T. T., Pierce, W. M., Markesbery, W. R., & Butterfield, D. A. (2009) · Brain Research · doi:10.1016/j.brainres.2009.04.009 · Cited by 190
α-synuclein implicated in Parkinson’s disease catalyses the formation of hydrogen peroxide in vitro
Turnbull, S., Tabner, B. J., El-Agnaf, O. M. A., Moore, S., Davies, Y., & Allsop, D. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00513-5 · Cited by 182
Green, A. R. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707594 · Cited by 177
Regulation of brain polyunsaturated fatty acid uptake and turnover
Chen, C. T., Green, J. T., Orr, S. K., & Bazinet, R. P. (2008) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2008.09.003 · Cited by 171
Castellani, R. J., Perry, G., Siedlak, S. L., Nunomura, A., Shimohama, S., Zhang, J., Montine, T., Sayre, L. M., & Smith, M. A. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02514-9 · Cited by 169
Ubiquinone-Dependent Recycling of Vitamin E Radicals by Superoxide
Stoyanovsky, D. A., Osipov, A. N., Quinn, P. J., & Kagan, V. E. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.9955 · Cited by 163
Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases
Brétillon, L., Sidén, Å., Wahlund, L., Lütjohann, D., Minthon, L., Crisby, M., Hillert, J. A., Groth, C., Diczfalusy, U., & Björkhem, I. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01466-x · Cited by 162
Recent developments in the pathology of Parkinson’s disease
Jellinger, K. A. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_33 · Cited by 157
Papassotiropoulos, A., Lütjohann, D., Bagli, M., Locatelli, S., Jessen, F., Rao, M. L., Maier, W., Björkhem, I., von Bergmann, K., & Heun, R. (2000) · Neuroreport · doi:10.1097/00001756-200006260-00030 · Cited by 151
Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations
Liu, Q., Smith, M. A., Ávila, J., DeBernardis, J. F., Kansal, M. M., Takeda, A., Zhu, X., Nunomura, A., Honda, K., Moreira, P. I., et al. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.11.005 · Cited by 145
Shichiri, M., Yoshida, Y., Ishida, N., Hagihara, Y., Iwahashi, H., Tamai, H., & Niki, E. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.03.023 · Cited by 133
Self-citationCell signalling by oxidized lipids and the role of reactive oxygen species in the endothelium
Zmijewski, J. W., Landar, A., Watanabe, N., Dickinson, D. A., Noguchi, N., & Darley-Usmar, V. M. (2005) · Biochemical Society Transactions · doi:10.1042/bst20051385 · Cited by 132
The Biochemistry of the Isoprostane, Neuroprostane, and Isofuran Pathways of Lipid Peroxidation
Roberts, L. J., Fessel, J. P., & Davies, S. S. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00511.x · Cited by 132
The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation
Roberts, L. J., & Fessel, J. P. (2003) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2003.09.016 · Cited by 128
24S-hydroxycholesterol in plasma: A marker of cholesterol turnover in neurodegenerative diseases
Leoni, V., & Caccia, C. (2012) · Biochimie · doi:10.1016/j.biochi.2012.09.025 · Cited by 128
Measurement of F2- isoprostanes and isofurans using gas chromatography–mass spectrometry
Milne, G. L., Gao, B., Terry, E. S., Zackert, W. E., & Sanchez, S. C. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.09.030 · Cited by 122
Early Glycoxidation Damage in Brains from Down's Syndrome
Odetti, P. R., Angelini, G., Dapino, D., Zaccheo, D., Garibaldi, S., Dagna-Bricarelli, F., Piombo, G., Perry, G. L., Smith, M. A., Traverso, N., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8186 · Cited by 118
F 2 -Isoprostanes in Alzheimer and Other Neurodegenerative Diseases
Montine, T. J., Montine, K. S., McMahan, W., Markesbery, W. R., Quinn, J. F., & Morrow, J. D. (2004) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.269 · Cited by 114
Ellis, J., Tan, H. K., Gilbert, R. E., Muller, D. P. R., Henley, W., Moy, R. J., Pumphrey, R., Ani, C. C., Davies, S., Edwards, V., et al. (2008) · BMJ · doi:10.1136/bmj.39465.544028.ae · Cited by 113
Yoshida, Y., Yoshikawa, A., Kinumi, T., Ogawa, Y., Saito, Y., Ohara, K., Yamamoto, H., Imai, Y., & Niki, E. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.06.012 · Cited by 110
Cerebrospinal fluid F 2 -isoprostanes are elevated in Huntington’s disease
Montine, T. J., Beal, M. F., Robertson, D., Cudkowicz, M., Biaggioni, I., O’Donnell, H., Zackert, W. E., Roberts, L. J., & Morrow, J. D. (1999) · Neurology · doi:10.1212/wnl.52.5.1104 · Cited by 103
Renić, M., Klaus, J. A., Omura, T., et al. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.156 · Cited by 97
Early oxidative stress in amniotic fluid of pregnancies with Down syndrome
Perrone, S., Longini, M., Bellieni, C. V., Centini, G., Kenanidis, A., Marco, L. D., Petraglia, F., & Buonocore, G. (2006) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.10.019 · Cited by 94
Fessel, J. P., Hulette, C., Powell, S. Z.-E., Roberts, L. J., & Zhang, J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01709.x · Cited by 90
Saito, Y., Hamakubo, T., Yoshida, Y., Ogawa, Y., Hara, Y., Fujimura, H., Imai, Y., Iwanari, H., Mochizuki, Y., Shichiri, M., et al. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.08.074 · Cited by 87
Self-citationCEASER, E. K., Moellering, D. R., Shiva, S., Ramachandran, A., Landar, A. L., Venkartraman, A., Crawford, J., Patel, R. P., Dickinson, D. A., Ulasova, E., et al. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320151 · Cited by 87
Antioxidants, Supplements, and Parkinson's Disease
Weber, C. A., & Ernst, M. E. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g551 · Cited by 86
Neurofurans, Novel Indices of Oxidant Stress Derived from Docosahexaenoic Acid
Song, W., Lawson, J. A., Reilly, D. F., Rokach, J., Chang, C.-T., Giasson, B. I., & FitzGerald, G. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706124200 · Cited by 82
Cell damage by excess CuZnSOD and down's syndrome
Groner, Y., Elroy-Sterol, O., Avraham, K. B., Schickler, M., Knobler, H. Y., Minc‐Golomb, D., Bar-Peled, O., Yarom, R., & Rotshenker, S. (1994) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(94)90138-4 · Cited by 80
Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer’s disease
Völkel, W., Sicilia, T., Pähler, A., Gsell, W., Tatschner, T., Jellinger, K., Leblhuber, F., Riederer, P., Lutz, W. K., & Götz, M. E. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2005.12.003 · Cited by 76
F4-neuroprostanes mediate neurological severity in Rett syndrome
Signorini, C., Felice, C. D., Leoncini, S., Giardini, A., D’Esposito, M., Filosa, S., Ragione, F. D., Rossi, M., Pecorelli, A., Valacchi, G., et al. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.04.016 · Cited by 76
Analysis of Cholesterol Oxidation Products in Biological Samples
Diczfalusy, U. (2004) · Journal of AOAC International · doi:10.1093/jaoac/87.2.467 · Cited by 75
Murphy, M. E., Kolvenbach, R. R., Aleksis, M., Hansen, R., & Sies, H. (1992) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(92)90069-s · Cited by 75
Ward, N. C., Croft, K. D., Blacker, D., Hankey, G. J., Barden, A. E., Mori, T. A., Puddey, I. B., & Etherton‐Beer, C. (2011) · Clinical Science · doi:10.1042/cs20110215 · Cited by 69
Resuscitation with supplementary oxygen induces oxidative injury in the cerebral cortex
Solberg, R., Longini, M., Proietti, F., Vezzosi, P., Saugstad, O. D., & Buonocore, G. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.07.022 · Cited by 67
Oxidative stress induces nuclear translocation of C-terminus of α-synuclein in dopaminergic cells
Xu, S., Zhou, M., Yu, S., Cai, Y., Zhang, A., Uéda, K., & Chan, P. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.148 · Cited by 61
Down syndrome gene dosage imbalance on cerebellum development
Moldrich, R. X., Dauphinot, L., Laffaire, J., Rossier, J., & Potier, M. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.02.006 · Cited by 61
Umeno, A., Shichiri, M., Ishida, N., Hashimoto, Y. K., Abe, K., Kataoka, M., Yoshino, K., Hagihara, Y., Aki, N., Funaki, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063542 · Cited by 60
Self-citationPlasma tocopherols and risk of cognitive impairment in an elderly Italian cohort
Ravaglia, G., Forti, P., Lucicesare, A., Pisacane, N., Rietti, E., Mangialasche, F., Cecchetti, R., Patterson, C., & Mecocci, P. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1306 · Cited by 59
Isoprostanes: an emerging role in vascular physiology and disease?
Cracowski, J. (2003) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2003.10.006 · Cited by 54
Hsieh, Y., Lin, C., Shiue, A.-L., Yin, H., Morrow, J. D., Hsu, J., Hsieh, T.-C., Wei, H.-J., & Yen, H. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.06.026 · Cited by 53
Tocopherylquinone and tocopherylhydroquinone
Niki, E. (2007) · Redox Report · doi:10.1179/135100007x200353 · Cited by 41
Increased Plasma Levels of Thioredoxin in Patients with Glucose Intolerance
Miyamoto, S., Kawano, H., Hokamaki, J., Soejima, H., Kojima, S., Kudoh, T., Nagayoshi, Y., Sugiyama, S., Sakamoto, T., Yoshimura, M., et al. (2005) · Internal Medicine · doi:10.2169/internalmedicine.44.1127 · Cited by 35
Chapter 23 Quantification of Superoxide Production by Mouse Brain and Skeletal Muscle Mitochondria
Malińska, D., Kudin, A. P., Dębska–Vielhaber, G., Vielhaber, S., & Kunz, W. S. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)04423-6 · Cited by 31
Elevation of oxidized DJ-1 in the brain and erythrocytes of Parkinson disease model animals
Ogawa, Y., Saito, Y., Hamakubo, T., Masuo, Y., Yoshida, Y., Nishio, K., Shichiri, M., Miyasaka, T., Iwanari, H., Mochizuki, Y., et al. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.08.007 · Cited by 31
Self-citationShichiri, M., Harada, N., Ishida, N., Komaba, L. K., Iwaki, S., Hagihara, Y., Niki, E., & Yoshida, Y. (2013) · Biological Psychology · doi:10.1016/j.biopsycho.2013.10.002 · Cited by 18
Self-citationPanasenko, O. M., Vakhrusheva, T. V., Vlasova, I. I., Chekanov, A. V., Baranov, Y. V., & Сергиенко, В. И. (2007) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-007-0346-x · Cited by 11
Cited by
Breakdown of an Ironclad Defense System: The Critical Role of NRF2 in Mediating Ferroptosis
Anandhan, A., Dodson, M., Schmidlin, C. J., Liu, P., & Zhang, D. D. (2020) · Cell Chemical Biology · doi:10.1016/j.chembiol.2020.03.011 · Cited by 442
Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration
Abdalkader, M., Lampinen, R., Kanninen, K. M., Malm, T. M., & Liddell, J. R. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00466 · Cited by 423
Emerging Risk Biomarkers in Cardiovascular Diseases and Disorders
Upadhyay, R. K. (2015) · Journal of Lipids · doi:10.1155/2015/971453 · Cited by 360
Kausar, S., Wang, F., & Cui, H. (2018) · Cells · doi:10.3390/cells7120274 · Cited by 311
Oxidative and nitrative stress in neurodegeneration
Cobb, C. A., & Cole, M. P. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.020 · Cited by 298
Metadata
- Authors
- Shichiri, M.
- Venue
- Journal of Clinical Biochemistry and Nutrition
- Published
- 2014
- Volume
- 54
- Issue
- 3
- Pages
- 151-160
- ISSN
- 0912-0009 (ISSN-L)
- 1880-5086
- OpenAlex
- W2089610248
- Cited by
- 269
- References
- 87
- FWCI
- 8.58
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.